20 October 2026

Champalimaud Foundation and Einstein Hospital Israelita strengthen scientific ties between Lisbon and São Paulo

The agreement between the Champalimaud Foundation and the Einstein Hospital Israelita covers seven areas of collaboration, including clinical, experimental and translational research, particularly in oncology and neuroscience; medical education and doctoral training; continuing professional development; clinical team development; patient safety and quality improvement; the exchange of healthcare technologies and solutions; and institutional ethics, integrity, compliance and governance.

19 Oct. 2026

Post-doctoral fellow (Cancer Dormancy & Immunity Lab)

Research
Application Starts: 19 Oct. 2026

 

The Cancer Dormancy & Immunity Lab headed by Ana Luísa Correia is seeking a highly motivated postdoctoral candidate
to join us on a project supported by an AACR Trailblazer grant.

Marco Emanuele

15 October 2026

Over €1.25 million awarded to three Champalimaud Foundation researchers for neuroscience and immunology

The three projects span very different areas of research. Moita, working in partnership with César Mendes at NOVA Medical School, will investigate how the brain and body produce the rapid defensive reactions that make us jump or flinch when startled. Van Gisbergen will study how certain immune cells establish themselves in the lungs, with the long-term goal of improving vaccines against influenza and other respiratory viruses.

Urgent decision making as a lens into the neural bases of behavior

Host

Alfonso Renart, PhD, Circuit Dynamics & Computation Lab


Venue

Seminar Room

02 October 2026

Science can be tasted, too

There is a line by British artist David Shrigley that goes: “I had no interest in it then I looked inside and now I'm enchanted by it.” In other words, it is difficult to be genuinely interested in something we know nothing about. First, we need the chance to take a look inside. To get closer. To explore. To ask questions. And sometimes, it is at that very moment, when something that once seemed distant becomes tangible, that fascination begins.
The same is true of science.

Translational advances in multiple myeloma: β-adrenergic blockade and strategies to overcome metabolite-driven resistance to BCL-2 antagonists

 Host

Cristina João, MD, PhD, Myeloma Lymphoma Lab


Venue

Seminar Room

01 October 2026

Turning patients' words into better care: Europe launches ResPECT AI assistant

Millions of people living with Breast cancer or depression experience physical, psychological, social and financial burdens that remain unseen or insufficiently addressed in routine care. Although patient-reported outcome measures exist and provide valuable insights, they often reduce complex patient experiences to numerical scores. At the same time, healthcare professionals face fragmented clinical data, increasing documentation demands and digital tools that are not always well integrated into care.

New Therapies: Neuromodulation and Rehabilitation

Beyond diagnosis, the Digital Neurotherapeutics Centre lets us take our mapping work directly into treatment. We're working to turn these tools, network mapping, neuromodulation, immersive behavioural platforms, into general principles that translate into both diagnosis and treatment. Refining DBS and TMS around the circuits our mapping identifies, and building immersive exergaming environments for movement and cognitive rehabilitation on the same programmable platforms we use to study behaviour.

Subscribe to Champalimaud Research
Loading
Please wait...